arginine has been researched along with aclarubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, D; Vincent, SR | 1 |
| Lorico, A; Rappa, G; Sartorelli, AC | 1 |
| Gahrton, G | 1 |
1 review(s) available for arginine and aclarubicin
| Article | Year |
|---|---|
Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Age Factors; Aminoacridines; Amsacrine; Anthraquinones; Antibodies, Monoclonal; Azacitidine; Bone Marrow Transplantation; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Infant; Interferons; Leukemia; Leukemia, Lymphoid; Liposomes; Middle Aged; Mitoxantrone; Naphthacenes; Prognosis; Teniposide; Transplantation, Homologous; Transplantation, Isogeneic; Vinblastine; Vindesine | 1983 |
2 other study(ies) available for arginine and aclarubicin
| Article | Year |
|---|---|
Inhibition of nitric oxide synthase by antineoplastic anthracyclines.
Topics: Aclarubicin; Amino Acid Oxidoreductases; Animals; Arginine; Brain Chemistry; Citrulline; Doxorubicin; Male; Nitric Oxide Synthase; Rats; Rats, Wistar | 1994 |
Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.
Topics: Aclarubicin; Animals; Cell Cycle; Cell Differentiation; Doxorubicin; Leukemia, Myelomonocytic, Chronic; Mice; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured | 1990 |